Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity
NCT00884247 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2010-12-07
Summary
The study aims to evaluate if a GERD treatment programme, in accordance with current regional recommendations, in a company health care setting, has an impact on health related quality of life (HRQoL), symptoms, and productivity in GERD patients.
Conditions
- GERD
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Svante Sjöstedt, MD, PhD · AstraZeneca Sweden
-
Dan Regberg, MD · AstraZeneca Sweden
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Completion
- 2009-06-30
Countries
- Sweden
More Related Trials
-
Outcomes for Patients With Gastro-Esophageal Reflux Disease
NCT03824548 ·Status: UNKNOWN
-
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
NCT00703534 ·Status: COMPLETED ·Phase: PHASE2
-
Symptom Adapted Therapy in GERD Patients
NCT00343161 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients
NCT00524251 ·Status: COMPLETED
-
Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.
NCT00786773 ·Status: COMPLETED
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERD
NCT00634023 ·Status: COMPLETED
-
Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use
NCT00691171 ·Status: COMPLETED
-
The Effect of Esomeprazole and Fundoplication on Airways
NCT00994708 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.
NCT01601379 ·Status: COMPLETED
-
Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational
NCT01378338 ·Status: COMPLETED
-
Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients
NCT01212614 ·Status: COMPLETED ·Phase: NA
-
Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments
NCT00688675 ·Status: COMPLETED
-
Retrospective Observational Study on GERD Management in General Hospitals in Korea
NCT06974903 ·Status: COMPLETED
-
Analysis of GERD Symptoms Using Gastroesophageal Reflux Impact Score Questionnaire for Quality of Life
NCT01536080 ·Status: COMPLETED
-
Impact of GERD on Daily Life (NIS)
NCT00545883 ·Status: COMPLETED
-
Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)
NCT00768443 ·Status: COMPLETED
-
Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ
NCT00914342 ·Status: COMPLETED
-
An Epidemiological Study to Describe Symptom Control and Impact of Gastroesophageal Reflux Disease
NCT01134367 ·Status: COMPLETED
-
Response to Supplement and Placebo in GERD
NCT01915173 ·Status: COMPLETED ·Phase: NA
-
National Survey on GERD Patients (Adults and Children)
NCT00833573 ·Status: COMPLETED
-
Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease
NCT01572974 ·Status: TERMINATED
-
What is the Predictive Value of the Reflux Impact Scale
NCT00536328 ·Status: TERMINATED
-
Influence of Acid Reflux on Stromal Epithelial Interaction in Barrett's Esophagus
NCT01281618 ·Status: COMPLETED
-
Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD
NCT02670642 ·Status: COMPLETED ·Phase: PHASE3